1naresh2naresh<pre>Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

    [cca5ee49-caca-40ed-9ae6-68d56c8a79f8] => Array
        (
            [runtime-id] => cca5ee49-caca-40ed-9ae6-68d56c8a79f8
            [type] => toll-free-key
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [1236042a-b351-46c9-bb1d-cd7ada5da884] => Array
                        (
                            [runtime-id] => 1236042a-b351-46c9-bb1d-cd7ada5da884
                            [type] => toll-free-key
                        )

                )

            [credentials] => Array
                (
                    [method] => toll-free-key
                    [value] => tf_ipsecsha;9a070ca4663cad035f2448c4e04a60b53216e811
                )

        )

)
1naresh2naresh<pre>Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => FreeToRead
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

    [26627763-dcd8-4bd4-a28f-c3b3ad61fdd2] => Array
        (
            [runtime-id] => 26627763-dcd8-4bd4-a28f-c3b3ad61fdd2
            [type] => toll-free-key
            [service-id] => ajnr-ac.highwire.org
            [access-type] => FreeToRead
            [privilege] => Array
                (
                    [bb04fe0e-a1c5-4369-96e7-cdc8e81604ff] => Array
                        (
                            [runtime-id] => bb04fe0e-a1c5-4369-96e7-cdc8e81604ff
                            [type] => toll-free-key
                        )

                )

            [credentials] => Array
                (
                    [method] => toll-free-key
                    [value] => tf_ipsecsha;9a070ca4663cad035f2448c4e04a60b53216e811
                )

        )

)
PT  - JOURNAL ARTICLE
AU  - Comin, J.
AU  - Kallmes, D.
TI  - Clopidogrel (Plavix)
AID  - 10.3174/ajnr.A2913
DP  - 2011 Dec 01
TA  - American Journal of Neuroradiology
PG  - 2002--2004
VI  - 32
IP  - 11
4099  - http://www.ajnr.org/content/32/11/2002.short
4100  - http://www.ajnr.org/content/32/11/2002.full
SO  - Am. J. Neuroradiol.2011 Dec 01; 32
AB  - SUMMARY: Clopidogrel is an inhibitor of platelet aggregation, indicated for the prevention of ischemic stroke and in-stent thrombosis. However, it has a number of drawbacks, including an increased risk of hemorrhage; a clinical effect that is slow in onset and irreversible; a genetically determined variability in its clinical potency; and interactions with other commonly administered drugs. Act-Metactive metabolite of clopidogrelADPadenosine diphosphateAHAAmerican Hospital AssociationGIgastrointestinalGPIIb/IIIaglycoprotein IIb/IIIaPPIproton pump inhibitorVWFvon Willebrand factor